MAPK1 and non-small cell lung carcinoma: Furthermore, in K-RAS driven non-small-cell lung carcinoma (NSCLC) in mouse models, ablation of either ERK1 or ERK2 yielded only minimal elongation of lifespan, because of compensatory functions of these two kinases to maintain the ERK signaling pathway [15].